Back to Walleye Capital LLC Walleye Capital LLC

NGNENGNE

Showing 6 of 9 quarters

Position history for Walleye Capital LLCWalleye Capital LLC's holdings in NEUROGENE INC

No. Walleye Capital exited its NGNE (Neurogene) position in Q1 2026. Its Q4 2025 13F listed 36,102 shares worth $743,701. Walleye Capital first reported NGNE in Q4 2023 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.9M

Total Shares Change

-44,500

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$21.99
0
2025-Q4
New
36,102
—
$743,7010.0%$22.11
34
2025-Q2
Exited
0
-100.0%
$00.0%$16.16
0
2025-Q1
Increased
94,083
+25.7%
$1.1M0.0%$14.52
31
2024-Q4
Increased
74,836
+68.2%
$1.7M0.0%$22.28
38
2024-Q3
Decreased
44,500
-51.9%
$1.9M0.0%$40.33
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used